Concepedia

Safety and Efficacy of <scp>Long‐Term</scp> Voclosporin Treatment for Lupus Nephritis in the Phase 3 <scp>AURORA</scp> 2 Clinical Trial

Amit Saxena, Ellen M. Ginzler, Keisha L. Gibson, Bancha Satirapoj, Adolfina Elizabeth Zuta Santillán, Olena Levchenko, Sandra Navarra, Tatsuya Atsumi, Shinsuke Yasuda, Nilmo Chávez-Pérez,

Arthritis & Rheumatology · 2023 · 90 citations · 17 references

DOIFull text

Open access

Abstract

Data demonstrate the safety and efficacy of long-term voclosporin treatment over three years of follow-up in patients with LN.

References

17

Trial of Anifrolumab in Active Systemic Lupus Erythematosus

Eric F. Morand, Richard Furie, Yoshiya Tanaka et al. · New England Journal of Medicine · 2019 · 1.2K citations · Full text

Relation Between Kidney Function, Proteinuria, and Adverse Outcomes

Brenda R. Hemmelgarn · JAMA · 2010 · 1K citations

Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis

Richard Furie, Brad H. Rovin, Frédéric Houssiau et al. · New England Journal of Medicine · 2020 · 903 citations · Full text

2019 Update of the Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the management of lupus nephritis

Antonis Fanouriakis, Myrto Kostopoulou, Kim Cheema et al. · Annals of the Rheumatic Diseases · 2020 · 771 citations · Full text

Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

Brad H. Rovin, Y K Onno Teng, Ellen M. Ginzler et al. · The Lancet · 2021 · 534 citations

, , +9